Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T68500 |
AZD-2207
|
Others | Others |
AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for the treatment of type 2 diabetes mellitus and obesity. |